Bab's Hobbs Pharma Guide

Tag: FDA

REMS for Isotretinoin: iPLEDGE Requirements and Safety in 2025
Justine Traver

REMS for Isotretinoin: iPLEDGE Requirements and Safety in 2025

iPLEDGE is the FDA's strict program to prevent birth defects from isotretinoin. Learn the 2025 requirements, recent changes, and how to navigate the system safely.

31 Dec 2025

Browse by category

  • Health & Wellness (225)

Latest news

  • Fildena Professional vs Other Sildenafil Options: A Detailed Comparison
  • Diarrhea: Understanding Acute vs. Chronic and When Antimotility Drugs Help
  • Compulsory Licensing: How Governments Override Patents to Save Lives
  • Colorectal Cancer Screening and Chemotherapy: What You Need to Know at 45 and Beyond
  • Transplant Immunosuppression: How Tacrolimus, Mycophenolate, and Steroids Work Together After Kidney Transplant

Posts Tags

  • drug interactions
  • online pharmacy
  • side effects
  • medication safety
  • bioequivalence
  • online pharmacy safety
  • medication reconciliation
  • patient safety
  • medication side effects
  • Hatch-Waxman Act
  • generic drugs
  • medication errors
  • generic medications
  • expired medications
  • medication adherence
  • generic medication
  • patent expiration
  • authorized generics
  • narrow therapeutic index
  • generic drug safety
Bab's Hobbs Pharma Guide
Menu
  • About
  • Terms of Service
  • Privacy Policy
  • GDPR Compliance
  • Contact

© 2026. All rights reserved.